355 related articles for article (PubMed ID: 22072556)
1. Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.
Srinivasan M; Flynn R; Price A; Ranger A; Browning JL; Taylor PA; Ritz J; Antin JH; Murphy WJ; Luznik L; Shlomchik MJ; Panoskaltsis-Mortari A; Blazar BR
Blood; 2012 Feb; 119(6):1570-80. PubMed ID: 22072556
[TBL] [Abstract][Full Text] [Related]
2. Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.
Flynn R; Du J; Veenstra RG; Reichenbach DK; Panoskaltsis-Mortari A; Taylor PA; Freeman GJ; Serody JS; Murphy WJ; Munn DH; Sarantopoulos S; Luznik L; Maillard I; Koreth J; Cutler C; Soiffer RJ; Antin JH; Ritz J; Dubovsky JA; Byrd JC; MacDonald KP; Hill GR; Blazar BR
Blood; 2014 Jun; 123(25):3988-98. PubMed ID: 24820310
[TBL] [Abstract][Full Text] [Related]
3. Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.
Du J; Paz K; Flynn R; Vulic A; Robinson TM; Lineburg KE; Alexander KA; Meng J; Roy S; Panoskaltsis-Mortari A; Loschi M; Hill GR; Serody JS; Maillard I; Miklos D; Koreth J; Cutler CS; Antin JH; Ritz J; MacDonald KP; Schacker TW; Luznik L; Blazar BR
Blood; 2017 May; 129(18):2570-2580. PubMed ID: 28254742
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice.
Wu Y; Schutt S; Paz K; Zhang M; Flynn RP; Bastian D; Sofi MH; Nguyen H; Dai M; Liu C; Chang YJ; Blazar BR; Yu XZ
Blood; 2018 Apr; 131(17):1974-1986. PubMed ID: 29530952
[TBL] [Abstract][Full Text] [Related]
5. Aberrant germinal center formation, follicular T-helper cells, and germinal center B-cells were involved in chronic graft-versus-host disease.
Shao L; Lie AK; Zhang Y; Wong CH; Kwong YL
Ann Hematol; 2015 Sep; 94(9):1493-504. PubMed ID: 25963280
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease.
Paz K; Flynn R; Du J; Qi J; Luznik L; Maillard I; MacDonald KP; Hill GR; Serody JS; Murphy WJ; Sage PT; Sharpe AH; Miklos D; Cutler CS; Koreth J; Antin JH; Soiffer RJ; Ritz J; Bradner JE; Melnick AM; Blazar BR
Blood; 2019 Jan; 133(1):94-99. PubMed ID: 30279226
[TBL] [Abstract][Full Text] [Related]
7. Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHD.
Kolupaev OV; Dant TA; Bommiasamy H; Bruce DW; Fowler KA; Tilley SL; McKinnon KP; Sarantopoulos S; Blazar BR; Coghill JM; Serody JS
Blood Adv; 2018 Sep; 2(18):2307-2319. PubMed ID: 30228128
[TBL] [Abstract][Full Text] [Related]
8. BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes.
Zaiken MC; Flynn R; Paz KG; Rhee SY; Jin S; Mohamed FA; Saha A; Thangavelu G; Park PMC; Hemming ML; Sage PT; Sharpe AH; DuPage M; Bluestone JA; Panoskaltsis-Mortari A; Cutler CS; Koreth J; Antin JH; Soiffer RJ; Ritz J; Luznik L; Maillard I; Hill GR; MacDonald KPA; Munn DH; Serody JS; Murphy WJ; Kean LS; Zhang Y; Bradner JE; Qi J; Blazar BR
Blood; 2022 May; 139(19):2983-2997. PubMed ID: 35226736
[TBL] [Abstract][Full Text] [Related]
9. Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice.
Radojcic V; Paz K; Chung J; Du J; Perkey ET; Flynn R; Ivcevic S; Zaiken M; Friedman A; Yan M; Pletneva MA; Sarantopoulos S; Siebel CW; Blazar BR; Maillard I
Blood; 2018 Nov; 132(20):2188-2200. PubMed ID: 30181175
[TBL] [Abstract][Full Text] [Related]
10. Extrafollicular CD4
Deng R; Hurtz C; Song Q; Yue C; Xiao G; Yu H; Wu X; Muschen M; Forman S; Martin PJ; Zeng D
Nat Commun; 2017 Oct; 8(1):978. PubMed ID: 29042531
[TBL] [Abstract][Full Text] [Related]
11. Targeting PI3Kδ function for amelioration of murine chronic graft-versus-host disease.
Paz K; Flynn R; Du J; Tannheimer S; Johnson AJ; Dong S; Stark AK; Okkenhaug K; Panoskaltsis-Mortari A; Sage PT; Sharpe AH; Luznik L; Ritz J; Soiffer RJ; Cutler CS; Koreth J; Antin JH; Miklos DB; MacDonald KP; Hill GR; Maillard I; Serody JS; Murphy WJ; Munn DH; Feser C; Zaiken M; Vanhaesebroeck B; Turka LA; Byrd JC; Blazar BR
Am J Transplant; 2019 Jun; 19(6):1820-1830. PubMed ID: 30748099
[TBL] [Abstract][Full Text] [Related]
12. C5aR1 regulates T follicular helper differentiation and chronic graft-versus-host disease bronchiolitis obliterans.
Verghese DA; Chun N; Paz K; Fribourg M; Woodruff TM; Flynn R; Hu Y; Xiong H; Zhang W; Yi Z; Du J; Blazar BR; Heeger PS
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568034
[TBL] [Abstract][Full Text] [Related]
13. BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation.
Jia W; Poe JC; Su H; Anand S; Matsushima GK; Rathmell JC; Maillard I; Radojcic V; Imai K; Reyes NJ; Cardona DM; Li Z; Suthers AN; Curry-Chisolm IM; DiCioccio RA; Saban DR; Chen BJ; Chao NJ; Sarantopoulos S
Blood; 2021 May; 137(18):2544-2557. PubMed ID: 33534893
[TBL] [Abstract][Full Text] [Related]
14. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.
Ohnuma K; Hatano R; Aune TM; Otsuka H; Iwata S; Dang NH; Yamada T; Morimoto C
J Immunol; 2015 Apr; 194(8):3697-712. PubMed ID: 25786689
[TBL] [Abstract][Full Text] [Related]
15. Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice.
Jin H; Ni X; Deng R; Song Q; Young J; Cassady K; Zhang M; Forman S; Martin PJ; Liu Q; Zeng D
Blood; 2016 May; 127(18):2249-60. PubMed ID: 26884373
[TBL] [Abstract][Full Text] [Related]
16. Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.
Flynn R; Allen JL; Luznik L; MacDonald KP; Paz K; Alexander KA; Vulic A; Du J; Panoskaltsis-Mortari A; Taylor PA; Poe JC; Serody JS; Murphy WJ; Hill GR; Maillard I; Koreth J; Cutler CS; Soiffer RJ; Antin JH; Ritz J; Chao NJ; Clynes RA; Sarantopoulos S; Blazar BR
Blood; 2015 Jun; 125(26):4085-94. PubMed ID: 25852057
[TBL] [Abstract][Full Text] [Related]
17. Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice.
Chen X; Wang Y; Huang X; Geng S; Li C; Zeng L; Huang L; Du X; Weng J; Lai P
Int Immunopharmacol; 2023 Apr; 117():109746. PubMed ID: 36827923
[TBL] [Abstract][Full Text] [Related]
18. Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.
Flynn R; Paz K; Du J; Reichenbach DK; Taylor PA; Panoskaltsis-Mortari A; Vulic A; Luznik L; MacDonald KK; Hill GR; Nyuydzefe MS; Weiss JM; Chen W; Trzeciak A; Serody JS; Aguilar EG; Murphy WJ; Maillard I; Munn D; Koreth J; Cutler CS; Antin JH; Ritz J; Waksal SD; Zanin-Zhorov A; Blazar BR
Blood; 2016 Apr; 127(17):2144-54. PubMed ID: 26983850
[TBL] [Abstract][Full Text] [Related]
19. Role of IL-26+CD26+CD4 T Cells in Pulmonary Chronic Graft-Versus-Host Disease and Treatment with Caveolin-1-Ig Fc Conjugate.
Ohnuma K; Hatano R; Itoh T; Iwao N; Dang NH; Morimoto C
Crit Rev Immunol; 2016; 36(3):239-267. PubMed ID: 28008806
[TBL] [Abstract][Full Text] [Related]
20. Strategies to inhibit alloantibody production in alloprimed murine recipients of hematopoietic stem cell grafts.
Blazar BR; Flynn R; Lee R; Marcucci G; Caliguiri MA; Heeger PS
Am J Transplant; 2015 Apr; 15(4):931-41. PubMed ID: 25762193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
